Načítá se...
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Tumor treatment is still complicated in the field of medicine. Tumor immunotherapy has been the most interesting research field in cancer therapy. Application of chimeric antigen receptor T (CAR-T) cell therapy has recently achieved excellent clinical outcome in patients, especially those with CD19-...
Uloženo v:
| Vydáno v: | Mol Cancer |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5956614/ https://ncbi.nlm.nih.gov/pubmed/29769134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-018-0840-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|